What is the appropriate assessment and management plan for a patient with a 70% stenosis of the right internal carotid artery and a 60% stenosis of the left internal carotid artery?

Assessment and Management of Right ICA 70% Stenosis and Left ICA 60% Stenosis

Critical First Determination: Symptomatic vs. Asymptomatic Status

The immediate priority is determining whether this patient is symptomatic (stroke, TIA, or amaurosis fugax within the past 6 months) or asymptomatic, as this fundamentally changes management. 1

If SYMPTOMATIC (stroke/TIA/amaurosis fugax within 6 months):

For the right ICA with 70% stenosis, carotid endarterectomy (CEA) is strongly recommended and should be performed within 14 days of the neurological event, provided the surgical team's documented 30-day risk of procedural death/stroke is <6%. 1

• The 70-99% symptomatic stenosis has Class I, Level A evidence for CEA 1
• Timing is critical: intervention within 14 days (ideally within 2 weeks) significantly improves outcomes 1
• CEA is generally preferred over carotid artery stenting (CAS), particularly if the patient is >70 years old 2, 1
• CAS may be considered if the patient is <70 years old or has unfavorable neck anatomy for surgery 1

For the left ICA with 60% stenosis, CEA should be considered (Class IIa recommendation) if symptomatic, provided the same <6% perioperative risk threshold is met. 1

• The 50-69% symptomatic stenosis range has weaker evidence than 70-99%, but intervention is still reasonable 1
• Patient factors including age, sex, comorbidities, and life expectancy >5 years should be considered 3

Immediate medical management for symptomatic patients:

• Dual antiplatelet therapy (DAPT) with aspirin (low-dose) plus clopidogrel 75 mg is mandatory for at least 21 days if not immediately revascularized 1
• After 21 days, transition to single antiplatelet therapy (clopidogrel 75 mg or aspirin) 1
• Assessment by a multidisciplinary vascular team including a neurologist is required 1

If ASYMPTOMATIC:

For asymptomatic disease, the approach is more conservative and requires careful patient selection.

The right ICA 70% stenosis may be considered for CEA only in highly selected patients who meet ALL of the following criteria: 2, 1, 4

• Life expectancy >5 years (preferably >3-5 years minimum) 2, 1, 5
• Surgical team with documented perioperative stroke/death rate <3% (note: stricter than symptomatic threshold) 2, 1
• Absence of significant comorbidities that increase surgical risk 2, 4
• Patient preference after shared decision-making 2, 5

The left ICA 60% stenosis in an asymptomatic patient does NOT meet threshold for routine revascularization. 2, 1

• Revascularization is not recommended for asymptomatic stenosis <70% 2, 1
• In the absence of high-risk features and with life expectancy <5 years, routine revascularization is explicitly not recommended 1

Medical management for asymptomatic patients (applies to BOTH lesions):

• Intensive lipid-lowering therapy targeting LDL-C <1.4 mmol/L (55 mg/dL) with >50% reduction from baseline 1
• High-dose statin therapy is mandatory 2, 3
• Single antiplatelet therapy: aspirin 75-325 mg daily OR clopidogrel 75 mg daily 2, 4, 6
• Aggressive blood pressure control 2, 1
• Diabetes management if present 2
• Smoking cessation 2
• Lifestyle modifications including diet and exercise 2

Diagnostic Confirmation

Duplex ultrasound (DUS) should be used as first-line imaging, with stenosis assessed using the NASCET method. 1

• If DUS results are inconclusive or surgical planning is needed, obtain CTA or MRA for confirmation 1
• Do NOT use the ECST method for stenosis assessment 1

Procedural Considerations if Revascularization Indicated

CEA is preferred over CAS in most scenarios, particularly for patients >70 years old. 2, 1

If CAS is chosen instead of CEA:

• DAPT with aspirin (81-325 mg) plus clopidogrel 75 mg must be started before the procedure and continued for at least 1 month post-procedure 1
• After 1 month, transition to long-term single antiplatelet therapy 1
• The interventionist must have documented expertise with perioperative stroke/death rates meeting guideline thresholds 2, 1

If CEA is performed:

• Aspirin 81-325 mg should be started before surgery and continued indefinitely 4
• Long-term antiplatelet therapy (aspirin, clopidogrel, or aspirin plus extended-release dipyridamole) is recommended 4

Follow-Up Protocol

Regardless of treatment strategy, all patients require:

• Annual follow-up to assess cardiovascular risk factors and treatment compliance 1
• Annual assessment of neurological symptoms 1
• DUS surveillance within the first month after any revascularization procedure 1
• Ongoing surveillance of the contralateral (untreated) stenosis with serial DUS 6

Critical Pitfalls to Avoid

Do NOT revascularize stenosis <50% except in extraordinary circumstances 4, 7

Do NOT delay CEA beyond 14 days in symptomatic patients who are clinically stable 1

Do NOT perform revascularization in asymptomatic patients with life expectancy <5 years or in the absence of high-risk features 1

Do NOT use anticoagulation as primary stroke prevention in carotid stenosis unless there is another indication (e.g., atrial fibrillation) 3

Ensure the surgical/interventional team meets the strict perioperative complication rate thresholds (<6% for symptomatic, <3% for asymptomatic) before proceeding 2, 1